NVO Q2 2020 Earnings Report — Novo Nordisk A/S Revenue & Financial Results | Market Cap Arena

Novo Nordisk A/SNVO

Q2 2020 Earnings

Reported June 29, 2020

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	Q2 2020	Q1 2020	Q2 2019	QoQ Change	YoY Change
Revenue	$4.7B	$5.3B	$4.7B	-11.4%	-0.1%
Op. Income	$2.2B	$2.6B	$2.1B	-15.1%	2.9%
Gross Margin	84.1%	84.1%	83.9%	-0.0pp	0.2pp
Net Margin	35.4%	35.1%	31.9%	0.3pp	3.5pp
EPS (Diluted)	$0.36	$0.40	$0.32	-10.3%	12.4%
Free Cash Flow	$3.6B	$1.3B	$1.9B	176.2%	86.7%

Revenue Flow

Item	Amount
REVENUE	$4.7B
Cost of Revenue	$748M
GROSS PROFIT	$4.0B
R&D Expenses	$516M
Selling & Marketing	$1.2B
General & Administrative	$130M
SG&A Expenses	$1.3B
Other Expenses	-$19M
Operating Expenses	$1.8B
Cost & Expenses	$2.5B
OPERATING INCOME	$2.2B
Interest Income	$15M
Interest Expense	$81M
Other Income/Expenses	-$66M
INCOME BEFORE TAX	$2.1B
Income Tax Expense	$437M
Net Income from Continuing Ops	$1.7B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.7B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.7B
D&A	$181M
EBIT	$2.2B
EBITDA	$2.4B
EPS	$0
EPS Diluted	$0

Income Statement

Item	Amount
REVENUE	$4.7B
Cost of Revenue	$748M
GROSS PROFIT	$4.0B
R&D Expenses	$516M
Selling & Marketing	$1.2B
General & Administrative	$130M
SG&A Expenses	$1.3B
Other Expenses	-$19M
Operating Expenses	$1.8B
Cost & Expenses	$2.5B
OPERATING INCOME	$2.2B
Interest Income	$15M
Interest Expense	$81M
Other Income/Expenses	-$66M
INCOME BEFORE TAX	$2.1B
Income Tax Expense	$437M
Net Income from Continuing Ops	$1.7B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.7B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.7B
D&A	$181M
EBIT	$2.2B
EBITDA	$2.4B
EPS	$0
EPS Diluted	$0

Cash Flow Statement

Item	Amount
Net Income	$1.7B
Depreciation & Amortization	$181M
Stock-Based Compensation	$0
Deferred Income Tax	$437M
Other Non-Cash Items	$416M
Change in Working Capital	$1.1B
OPERATING CASH FLOW	$3.8B
Capital Expenditure	-$214M
Acquisitions (Net)	$0
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	-$20M
NET CASH FROM INVESTING	-$214M
Net Debt Issuance	-$1M
Common Stock Repurchased	-$865M
Common Dividends Paid	$0
Other Financing Activities	-$337M
NET CASH FROM FINANCING	-$1.2B
FREE CASH FLOW	$3.6B
Net Change in Cash	$2.4B

Balance Sheet

Item	Amount
Cash & Equivalents	$587M
Short-Term Investments	$0
Net Receivables	$613M
Inventory	$420M
Other Current Assets	$117M
TOTAL CURRENT ASSETS	$1.7B
PP&E (Net)	$1.2B
Goodwill	$0
Intangible Assets	$137M
Long-Term Investments	$44M
Tax Assets	$89M
Other Non-Current Assets	$15M
TOTAL NON-CURRENT ASSETS	$1.5B
TOTAL ASSETS	$3.2B
Account Payables	$212M
Short-Term Debt	$33M
Deferred Revenue	$0
Other Current Liabilities	$1.3B
TOTAL CURRENT LIABILITIES	$1.6B
Long-Term Debt	$65M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$6M
Other Non-Current Liabilities	$137M
TOTAL NON-CURRENT LIABILITIES	$207M
TOTAL LIABILITIES	$1.8B
Common Stock	$11M
Additional Paid-In Capital	$0
Retained Earnings	$1.4B
Treasury Stock	-$70.8K
Accum. Other Comp. Income	-$10M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$1.4B
Minority Interest	$0
TOTAL EQUITY	$1.4B
TOTAL LIABILITIES & EQUITY	$3.2B
Total Debt	$98M
Net Debt	-$489M